药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cefotetan
Coagulation factor X human
The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Vorapaxar.
Cefotetan
Von Willebrand Factor Human
The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Vorapaxar.
Cefotetan
Factor XIII (human)
The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Vorapaxar.
Cefotetan
Vatreptacog alfa
The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Vorapaxar.
Cefotetan
Rusalatide acetate
The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Vorapaxar.
Cefotetan
Eftrenonacog alfa
The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Vorapaxar.
Cefotetan
Susoctocog alfa
The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Vorapaxar.
Cefotetan
Calcium Phosphate
The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Vorapaxar.
Cefotetan
Factor IX Complex (Human)
The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Vorapaxar.
Cefotetan
Prothrombin
The therapeutic efficacy of Prothrombin can be decreased when used in combination with Vorapaxar.
Cefotetan
Calcium threonate
The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Vorapaxar.
Cefotetan
Calcium gluconate
The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Vorapaxar.
Cefotetan
Calcium citrate
The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Vorapaxar.
Cefotetan
Antihemophilic Factor (Recombinant), PEGylated
The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Vorapaxar.
Cefotetan
Catridecacog
The therapeutic efficacy of Catridecacog can be decreased when used in combination with Vorapaxar.
Cefotetan
Fibrinogen human
The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Vorapaxar.
Cefotetan
Turoctocog alfa
The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Vorapaxar.
Cefotetan
Calcium carbonate
The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Vorapaxar.
Cefotetan
Pantothenic acid
The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Vorapaxar.
Cefotetan
Calcium
The therapeutic efficacy of Calcium can be decreased when used in combination with Vorapaxar.